Physician profile
Michael Yost
NPI 1225001019
$8,929.65
in general payments reported to CMS, 2019-2025
8 companies · $3,471 in 2025
The $3,471 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.23 · 2020: $59.24 · 2021: $46.89 · 2022: $3,141 · 2023: $719 · 2024: $1,423 · 2025: $3,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,244 · Travel and Lodging: $2,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,244.18 |
| Travel and Lodging | $2,369.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,248.55 | 2020-2025 | Salvation, Inspace, Mako |
| Pylant Medical | $313.43 | 2021-2025 | |
| Depuy Synthes Sales INC. | $134.43 | 2022 | |
| Anika Therapeutics, INC. | $83.05 | 2023-2025 | Integrity Implant, Revomotion |
| Lima USA, INC. | $69.23 | 2019 | |
| Ethicon US, LLC | $35.82 | 2025 | Vistaseal, Ethicon |
| Vericel Corporation | $24.55 | 2023 | Maci |
| Linvatec Corporation | $20.59 | 2023 | Biobrace 23mm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Yost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.